Crop Life Science Ltd.
•₹ 80-3.21%
2026-08-21
PROS
CONS
- Operating cash flow has been negative in recent years
- Poor cash conversion - profits are not backed by operating cash flow (CFO/PAT -0.52x)
- Company has a low return on equity of 9.4% over last 3 years
- Free cash flow has been persistently negative
- Though reporting repeated profits, the company pays out little dividend (0.0%)
- Debtor days have increased from 101 to 133
* The pros and cons are machine generated based on quantitative rules.
Peer comparison
EDIT COLUMNS| S.No. | Name | CMP Rs. | P/E | Mar Cap Rs.Cr. | Div Yld % | NP Qtr Rs.Cr. | Qtr Profit Var % | Sales Qtr Rs.Cr. | Qtr Sales Var % | ROCE % | OPM % |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 1. | UPL | 568.70 | 23.77 | 48007.91 | 1.05 | -73.00 | 58.52 | 10181.00 | 10.47 | 12.00 | 13.43 |
| 2. | PIIND | 2496.00 | 32.51 | 37868.84 | 0.60 | 244.20 | -38.95 | 1702.30 | -10.43 | 16.00 | 21.69 |
| 3. | SUMICHEM | 553.65 | 47.69 | 27635.20 | 0.23 | 214.51 | 20.45 | 1063.35 | 0.62 | 23.39 | 21.94 |
| 4. | BAYERCROP | 4068.40 | 329.99 | 18284.24 | 3.69 | 321.60 | 15.39 | 1835.00 | -4.16 | 30.08 | 20.03 |
| 5. | SHARDACROP | 771.80 | 11.12 | 6963.22 | 1.94 | 88.02 | -38.36 | 1073.77 | 9.03 | 31.10 | 17.32 |
| 6. | DHANUKA | 995.20 | 14.94 | 4436.43 | 0.20 | 75.50 | 27.94 | 442.02 | 20.01 | 24.44 | 24.83 |
| 7. | RALLIS | 211.90 | 25.10 | 4120.80 | 1.42 | -14.15 | -274.26 | 507.54 | 7.70 | 13.23 | -0.56 |
| 8. | NACLIND | 174.00 | 329.49 | 4075.83 | 0.00 | 20.84 | 59.82 | 383.33 | -14.50 | 6.20 | 10.80 |
| 9. | BHAGCHEM | 290.25 | 136.75 | 3763.65 | 0.05 | 133.29 | 3249.84 | 1950.19 | 1475.55 | 4.55 | 15.65 |
| 10. | GSPCROP | 595.35 | 28.29 | 2769.49 | 0.17 | 263.94 | 1111.46 | 3859.95 | 1153.27 | 20.81 | 11.02 |
| 11. | BHARATRAS | 1279.90 | 14.85 | 2127.33 | 0.04 | 372.30 | 838.73 | 3381.60 | 796.03 | 16.63 | 15.19 |
| 12. | CLSL | 79.40 | 20.51 | 136.09 | 0.00 | — | — | — | — | 11.35 | — |
Detailed Comparison with:
Quarterly Results
Consolidated Figures in Rs. Crores / View Standalone
No quarterly results found
We don't have this information yet. Please check back later.
Profit & Loss
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|
| 131 | 199 | 201 | |
| 119 | 186 | 185 | |
| Operating Profit | 13 | 15 | 17 |
| OPM % | 10 | 7 | 9 |
| Other Income | 1 | 2 | 2 |
| Interest | 3 | 3 | 5 |
| Depreciation | 4 | 3 | 5 |
| 6 | 8 | 8 | |
| Tax % | 27 | 26 | 28 |
| Net Profit | 4 | 6 | 6 |
| EPS | 3 | 4 | 3 |
| Dividend Payout % | 0 | 0 | 0 |
| Minority Interest | 0 | 0 | 0 |
| Share of Associates | 0 | 0 | 0 |
| Adjusted EPS | 3 | 4 | 3 |
| Minority Interest | 0 | 0 | 0 |
| Share of Associates | 0 | 0 | 0 |
| Adjusted EPS | 3 | 4 | 3 |
Mar 2023
- 131
- 119
- Operating Profit
- 13
- OPM %
- 10
- Other Income
- 1
- Interest
- 3
- Depreciation
- 4
- 6
- Tax %
- 27
- Net Profit
- 4
- EPS
- 3
- Dividend Payout %
- 0
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- 3
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- 3
Mar 2024
- 199
- 186
- Operating Profit
- 15
- OPM %
- 7
- Other Income
- 2
- Interest
- 3
- Depreciation
- 3
- 8
- Tax %
- 26
- Net Profit
- 6
- EPS
- 4
- Dividend Payout %
- 0
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- 4
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- 4
Mar 2025
- 201
- 185
- Operating Profit
- 17
- OPM %
- 9
- Other Income
- 2
- Interest
- 5
- Depreciation
- 5
- 8
- Tax %
- 28
- Net Profit
- 6
- EPS
- 3
- Dividend Payout %
- 0
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- 3
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- 3
COMPOUNDED SALES GROWTH
- 10 Years:
- —
- 5 Years:
- —
- 3 Years:
- —
COMPOUNDED PROFIT GROWTH
- 10 Years:
- —
- 5 Years:
- —
- 3 Years:
- —
STOCK PRICE CAGR
- 10 Years:
- —
- 5 Years:
- —
- 3 Years:
- —
- 1 Year:
- 23%
RETURN ON EQUITY
- 10 Years:
- —
- 5 Years:
- —
- 3 Years:
- 9%
- Last Year:
- 8%
Balance Sheet
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|
| LIABILITIES | - | - | - |
| Equity Capital | 12 | 17 | 17 |
| 29 | 55 | 60 | |
| 18 | 24 | 35 | |
| Trade Payables | 20 | 53 | 42 |
| 24 | 33 | 30 | |
| Total Liabilities | 103 | 182 | 184 |
| ASSETS | - | - | - |
| 16 | 39 | 38 | |
| 0 | 0 | 1 | |
| 26 | 40 | 49 | |
| 0 | 77 | 69 | |
| Cash & Bank | 0 | 2 | 1 |
| 61 | 23 | 26 | |
| Total Assets | 103 | 182 | 184 |
| Total Debt | 26 | 31 | 41 |
| Net Working Capital | 31 | 47 | 49 |
| Contingent Liabilities | 2 | 2 | 1 |
| Book Value per Share | 33.80 | 41.85 | 45.19 |
| Face Value | 10.00 | 10.00 | 10.00 |
| Total Debt | 26 | 31 | 41 |
| Net Working Capital | 31 | 47 | 49 |
| Contingent Liabilities | 2 | 2 | 1 |
| Book Value per Share | 33.80 | 41.85 | 45.19 |
| Face Value | 10.00 | 10.00 | 10.00 |
Mar 2023
- Equity Capital
- 12
- 29
- 18
- Trade Payables
- 20
- 24
- Total Liabilities
- 103
- 16
- 0
- 26
- 0
- Cash & Bank
- 0
- 61
- Total Assets
- 103
- Total Debt
- 26
- Net Working Capital
- 31
- Contingent Liabilities
- 2
- Book Value per Share
- 33.80
- Face Value
- 10.00
- Total Debt
- 26
- Net Working Capital
- 31
- Contingent Liabilities
- 2
- Book Value per Share
- 33.80
- Face Value
- 10.00
Mar 2024
- Equity Capital
- 17
- 55
- 24
- Trade Payables
- 53
- 33
- Total Liabilities
- 182
- 39
- 0
- 40
- 77
- Cash & Bank
- 2
- 23
- Total Assets
- 182
- Total Debt
- 31
- Net Working Capital
- 47
- Contingent Liabilities
- 2
- Book Value per Share
- 41.85
- Face Value
- 10.00
- Total Debt
- 31
- Net Working Capital
- 47
- Contingent Liabilities
- 2
- Book Value per Share
- 41.85
- Face Value
- 10.00
Mar 2025
- Equity Capital
- 17
- 60
- 35
- Trade Payables
- 42
- 30
- Total Liabilities
- 184
- 38
- 1
- 49
- 69
- Cash & Bank
- 1
- 26
- Total Assets
- 184
- Total Debt
- 41
- Net Working Capital
- 49
- Contingent Liabilities
- 1
- Book Value per Share
- 45.19
- Face Value
- 10.00
- Total Debt
- 41
- Net Working Capital
- 49
- Contingent Liabilities
- 1
- Book Value per Share
- 45.19
- Face Value
- 10.00
Cash Flows
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|
| 2 | -8 | -2 | |
| Cash from Investing | -4 | -3 | -4 |
| Cash from Financing | 1 | 13 | 4 |
| -2 | 2 | -1 | |
| Free Cash Flow | 2 | -42 | -6 |
| OCF / Net Profit | 0.56 | -1.39 | -0.37 |
| Cumulative 5-Year FCF | 0 | 0 | 0 |
| OCF / Net Profit | 0.56 | -1.39 | -0.37 |
| Cumulative 5-Year FCF | 0 | 0 | 0 |
Mar 2023
- 2
- Cash from Investing
- -4
- Cash from Financing
- 1
- -2
- Free Cash Flow
- 2
- OCF / Net Profit
- 0.56
- Cumulative 5-Year FCF
- 0
- OCF / Net Profit
- 0.56
- Cumulative 5-Year FCF
- 0
Mar 2024
- -8
- Cash from Investing
- -3
- Cash from Financing
- 13
- 2
- Free Cash Flow
- -42
- OCF / Net Profit
- -1.39
- Cumulative 5-Year FCF
- 0
- OCF / Net Profit
- -1.39
- Cumulative 5-Year FCF
- 0
Mar 2025
- -2
- Cash from Investing
- -4
- Cash from Financing
- 4
- -1
- Free Cash Flow
- -6
- OCF / Net Profit
- -0.37
- Cumulative 5-Year FCF
- 0
- OCF / Net Profit
- -0.37
- Cumulative 5-Year FCF
- 0
Ratios
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|
| PER SHARE | - | - | - |
| EPS (₹) | 3.39 | 3.51 | 3.44 |
| Book Value (₹) | 33.80 | 41.85 | 45.19 |
| Dividend per Share (₹) | 0.00 | 0.00 | 0.00 |
| Cash EPS (₹) | 6.48 | 5.39 | 6.08 |
| PROFITABILITY | - | - | - |
| Operating Margin % | 9.58% | 6.35% | 7.75% |
| Net Margin % | 3.10% | 3.03% | 2.79% |
| ROE % | 10.04% | 10.72% | 7.51% |
| ROCE % | 13.33% | 13.56% | 11.35% |
| 3.95% | 4.22% | 3.06% | |
| EFFICIENCY | - | - | - |
| Debtor Days | 91 | 101 | 133 |
| Inventory Days | 73 | 61 | 81 |
| Payable Days | 79 | 91 | 121 |
| 84 | 71 | 93 | |
| FINANCIAL HEALTH | - | - | - |
| Debt to Equity (x) | 0.64x | 0.44x | 0.52x |
| Interest Coverage (x) | 2.71x | 3.39x | 2.64x |
| 1.55x | 1.50x | 1.52x | |
| GROWTH | - | - | - |
| Revenue Growth % | 0.00% | 51.35% | 1.00% |
| Operating Profit Growth % | 0.00% | 17.09% | 17.99% |
| Net Profit Growth % | 0.00% | 47.77% | -6.90% |
| 0.00% | 3.58% | -2.19% | |
| VALUATION | - | - | - |
| P/E (x) | 0.00x | 10.47x | 14.84x |
| P/B (x) | 0.00x | 0.88x | 1.13x |
| Dividend Yield % | 0.00% | 0.00% | 0.00% |
| 0.00x | 6.24x | 7.31x |
Mar 2023
- EPS (₹)
- 3.39
- Book Value (₹)
- 33.80
- Dividend per Share (₹)
- 0.00
- Cash EPS (₹)
- 6.48
- Operating Margin %
- 9.58%
- Net Margin %
- 3.10%
- ROE %
- 10.04%
- ROCE %
- 13.33%
- 3.95%
- Debtor Days
- 91
- Inventory Days
- 73
- Payable Days
- 79
- 84
- Debt to Equity (x)
- 0.64x
- Interest Coverage (x)
- 2.71x
- 1.55x
- Revenue Growth %
- 0.00%
- Operating Profit Growth %
- 0.00%
- Net Profit Growth %
- 0.00%
- 0.00%
- P/E (x)
- 0.00x
- P/B (x)
- 0.00x
- Dividend Yield %
- 0.00%
- 0.00x
Mar 2024
- EPS (₹)
- 3.51
- Book Value (₹)
- 41.85
- Dividend per Share (₹)
- 0.00
- Cash EPS (₹)
- 5.39
- Operating Margin %
- 6.35%
- Net Margin %
- 3.03%
- ROE %
- 10.72%
- ROCE %
- 13.56%
- 4.22%
- Debtor Days
- 101
- Inventory Days
- 61
- Payable Days
- 91
- 71
- Debt to Equity (x)
- 0.44x
- Interest Coverage (x)
- 3.39x
- 1.50x
- Revenue Growth %
- 51.35%
- Operating Profit Growth %
- 17.09%
- Net Profit Growth %
- 47.77%
- 3.58%
- P/E (x)
- 10.47x
- P/B (x)
- 0.88x
- Dividend Yield %
- 0.00%
- 6.24x
Mar 2025
- EPS (₹)
- 3.44
- Book Value (₹)
- 45.19
- Dividend per Share (₹)
- 0.00
- Cash EPS (₹)
- 6.08
- Operating Margin %
- 7.75%
- Net Margin %
- 2.79%
- ROE %
- 7.51%
- ROCE %
- 11.35%
- 3.06%
- Debtor Days
- 133
- Inventory Days
- 81
- Payable Days
- 121
- 93
- Debt to Equity (x)
- 0.52x
- Interest Coverage (x)
- 2.64x
- 1.52x
- Revenue Growth %
- 1.00%
- Operating Profit Growth %
- 17.99%
- Net Profit Growth %
- -6.90%
- -2.19%
- P/E (x)
- 14.84x
- P/B (x)
- 1.13x
- Dividend Yield %
- 0.00%
- 7.31x
Documents
Announcements
Nothing filed yet.
Annual Reports
Credit Ratings
Nothing filed yet.
Concalls
Nothing filed yet.

